| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Owner | Director, 10% Owner
5 companies
Gadicke Ansbert is a Director, 10% Owner at KLRS, with reported holdings spanning 5 companies. Recent filings cover 4 purchases and 117 sales. Those positions are worth an estimated $434.2M at current prices.
Our model assigns Gadicke Ansbert a strong insider score of 85/100, based on 79 past trades. Over a 12-month horizon, 98.0% of those trades were profitable, with an average 12-month return of +56.6%.
Gadicke Ansbert's largest disclosed position is in CGEM as Director, 10% Owner, worth about $222.3M. The recent filings there lean toward selling, a net 2,396 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | 10% Owner | Buy | 1,112,777 | $18.00 | $20,029,986.00 | +12.2% | -20.3% | - | |
| Dec 4, 2025 | HOWL Werewolf Therapeutics, Inc. | Former 10% Owner | Sell | 199,732 | $0.92 | $183,275.38 | -4.0% | -38.8% | - | |
| Dec 1, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell | 141,927 | $0.96 | $136,854.55 | -2.8% | -36.4% | - | |
| Nov 25, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell | 195,666 | $0.92 | $179,551.05 | -3.7% | -27.5% | - | |
| Nov 20, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell | 160,103 | $0.92 | $147,912.95 | -2.9% | -22.9% | - | |
| Nov 17, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell | 209,652 | $0.96 | $200,665.13 | -3.7% | -28.4% | - | |
| Nov 12, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell | 213,529 | $1.13 | $241,278.01 | -3.6% | -34.2% | - | |
| Nov 6, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell | 242,890 | $1.22 | $295,781.28 | -4.0% | -46.5% | - | |
| Nov 3, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell | 295,043 | $1.33 | $391,636.07 | -4.6% | -48.2% | - | |
| Oct 29, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell | 276,017 | $1.62 | $446,403.00 | -4.1% | -57.0% | - |